Identifying different phenotypes in takotsubo cardiomyopathy by latent class analysis
Related Experiment Video
Updated: Nov 28, 2025

Assessing Cardiomyocyte Subtypes Following Transcription Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts
Published on: March 22, 2017
Pengyang Li1, Qiying Dai2, Peng Cai3
1Department of Medicine, Saint Vincent Hospital, Worcester, MA, USA.
Insights
Latent class analysis identified four distinct clinical phenotypes in takotsubo cardiomyopathy (TCM) patients. These clusters, based on demographics and comorbidities, may guide targeted treatments and clinical trials for this heterogeneous heart condition.
Area of Science:
- Cardiology
- Medical Informatics
- Clinical Research
Background:
- Takotsubo cardiomyopathy (TCM) is a complex heart condition with poorly understood causes.
- TCM presents as a heterogeneous disorder, necessitating a deeper understanding of its varied clinical presentations.
Purpose of the Study:
- To identify distinct clinical clusters within takotsubo cardiomyopathy patient population.
- To better understand the heterogeneity of TCM through phenotyping.
Main Methods:
- Latent class analysis (LCA) was performed on a large sample of 3139 TCM patients from the National Inpatient Sample (NIS) database (2016-2017).
- Analysis utilized patient demographics and comorbidities including age, sex, hypertension, hyperlipidaemia, diabetes, obesity, smoking, COPD, and anxiety/depressive disorders.
- Results were validated using separate 2016 and 2017 NIS datasets, and in-hospital outcomes were compared across identified clusters.
Main Results:
- Four distinct clinical phenotypes (clusters) of TCM were identified.
- Cluster 1 (39.4%) showed high prevalence of hyperlipidaemia, hypertension, and diabetes, with lowest in-hospital mortality (1.0%) and shortest length of stay.
- Cluster 2 (14.0%) comprised patients with COPD and smoking history, exhibiting the highest in-hospital mortality (3.4%). Cluster 3 (11.8%) consisted of patients with anxiety and depressive disorders.
- Cluster 4 (34.8%) represented patients with isolated TCM and minimal comorbidities.
Conclusions:
- The identified clinical phenotypes may represent different underlying pathophysiological processes in TCM.
- These findings can aid in identifying specific treatment targets for TCM.
- The identified clusters can assist in patient selection for future clinical trials in takotsubo cardiomyopathy research.
Aims:
This study sought to determine whether clinical clusters exist in takotsubo cardiomyopathy. Takotsubo cardiomyopathy (TCM) is a heterogeneous disorder with a complex, poorly understood pathogenesis. To better understand the heterogeneity of TCM, we identified different clinical phenotypes in a large sample of TCM patients by using latent class analysis (LCA).
Methods And Results:
Using the National Inpatient Sample (NIS) database, we identified 3139 patients admitted to hospitals in 2016-2017 with a primary diagnosis of TCM. We performed LCA based on several patient demographics and comorbidities: age, sex, hypertension, hyperlipidaemia, diabetes mellitus, obesity, current smoking, asthma, chronic obstructive pulmonary disease (COPD), and anxiety and depressive disorders. We then repeated LCA separately with the NIS 2016 and 2017 data sets and performed a robust test to validate our results. We also compared in-hospital outcomes among the different clusters identified by LCA. Four patient clusters were identified. C1 (n = 1228, 39.4%) had the highest prevalence of hyperlipidaemia (93.4%), hypertension (61.6%), and diabetes (34.3%). In C2 (n = 440, 14.0%), all patients had COPD, and many were smokers (45.8%). C3 (n = 376, 11.8%) largely comprised patients with anxiety disorders (98.4%) and depressive disorders (80.1%). C4 (n = 1097, 34.8%) comprised patients with isolated TCM and few comorbidities. Among all clusters, C1 had the lowest in-hospital mortality (1.0%) and the shortest length of stay (3.2 ± 3.1 days), whereas C2 had the highest in-hospital mortality (3.4%).
Conclusions:
Using LCA, we identified four clinical phenotypes of TCM. These may reflect different pathophysiological processes in TCM. Our findings may help identify treatment targets and select patients for future clinical trials.
Related Concept Videos
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Heart Failure IV: Classification and Diagnostic Evaluation
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy V: Interprofessional Care

